C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/18 (2006.01) A61K 39/395 (2006.01) C07K 14/82 (2006.01) C07K 16/32 (2006.01) C07K 16/46 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2236913
Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells are disclosed. The antibodies are used to "tag" Her2 overexpressing tumors for elimination by the host immune system. Also disclosed are hybridoma cell lines producing the antibodies, methods for treating cancer using the antibodies, and pharmaceutical compositions.
L'invention concerne des anticorps anti-Her2 provoquant l'apoptose dans des cellules exprimant Her2. On utilise ces anticorps afin de "marquer" des tumeurs surexprimant Her2, afin qu'elles soient éliminées par le système immun de l'hôte. L'invention concerne également des lignées cellulaires d'hybridomes produisant ces anticorps, des procédés servant à traiter le cancer au moyen de ces anticorps, ainsi que des compositions pharmaceutiques.
Arakawa Tsutomu
Kita Yoshiko A.
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Apoptosis induced by monoclonal antibody anti-her2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apoptosis induced by monoclonal antibody anti-her2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptosis induced by monoclonal antibody anti-her2 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2010085